NEWARK, Del, April 27, 2023 (GLOBE NEWSWIRE) -- The global superficial punctate keratitis treatment market is slated to reach a valuation of US$ 5.3 Billion in 2023. According to Future Market ...

Superior limbic keratoconjunctivitis (SLK) Bilateral superior bulbar injection, laxity, ... multifocal epithelial punctate keratitis evolving to anterior stromal keratitis, ...

The global superficial punctate keratitis treatment market is slated to reach a valuation of US$ 5.3 billion in 2023. According to Future Market Insights, the market is expected to grow at a 6.33% ...

Did you know that certain medications can cause symptom of 'Superficial punctate keratopathy'. Find these drugs listed on the page and be warned of similar symptoms as possible side-effects.

The global superficial punctate keratitis treatment market is slated to reach a valuation of US$ 5.3 billion in 2023. According to Future Market Insights, the market is expected to grow at a 6.33% ...

In clinical trials, the most common side effect for XDEMVY was stinging and burning in 10% of patients, and, in rare cases (less than 2% of patients), chalazion/hordeolum and punctate keratitis.

Patient 1 was a 48-year-old woman with metastatic breast cancer, a history of keratoconjunctivitis sicca, and 20/20 visual acuity in each eye who had severe bilateral irritation and decreased ...

Did you know that certain medications can cause symptom of 'Punctate keratitis'. Find these drugs listed on the page and be warned of similar symptoms as possible side-effects.